Evofem Biosciences, Inc. (EVFM) stock
EVFMOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-10.00%)
Close on Oct 19, 2026Market cap $865.23KP/E –Yield –
Evofem Biosciences pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Evofem Biosciences's pe ratio was 2.1× on Apr 30, 2026, against 0.3× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 2.1× | +1.9 |
| 2025 | Jan 31, 2025 | 0.2× | −0.0 |
| 2024 | Dec 31, 2024 | 0.2× | +0.2 |
| 2023 | Dec 29, 2023 | 0.0× | – |
See a number that looks wrong?